Introduction
Genital herpes is a major public health problem worldwide . Genital herpes is most frequently caused by the Herpes Simplex Virus [1 ] type 2 (HSV-2). Clinical, biological and epidemiological studies support the hypothesis that HSV-2 increases the risk of HIV-1 acquisition 2-to 4-fold and increases the risk of HIV-1 transmission , . A recent meta analysis found that genital ulcer disease 
) .
-] [15 ] HIV, in turn, increases the risk of HSV-2 transmission . There is a direct relationship between CD4 cell count and the rate of [ 
] +
HSV-2 reactivation. Outbreaks of HSV-2 are more severe, extensive, persistent, and invasive for those with advanced HIV disease , [14 . Persistent HSV-2 infection was one of the original opportunistic infections that resulted in the identification of AIDS . 16 ]
[17 ]
Three randomized controlled trials have demonstrated that male circumcision reduces the female-to-male sexual transmission of HIV by about 60 . A meta-analysis of observational data showed that male circumcision reduces the risk of HSV-2 infection with a % [18 -20 ] borderline statistical significance (summary RR, 0.88 95 CI, 0.77 1.01 ) .
[ % -] [21 ] The main objectives of this study were to estimate a) the effect of HSV-2 status on HIV incidence among young males b) the population fraction of HIV infections attributable to HSV-2 infection and c) the effect of HSV-2 status on the protective effect of male circumcision on HIV acquisition by men. The secondary objective was to study the risk factors of HSV-2 incidence, especially the effect of male circumcision.
For these analyses, we used data collected during a male circumcision randomized controlled trial conducted in Orange Farm (South Africa), which demonstrated a reducing effect of male circumcision on the acquisition of HIV .
[18 ]
Methods

Collection of data
The technical details of the trial (ANRS-1265), description of the participants and HIV testing methods having been published elsewhere , only a summary will be presented in this article. Between February 2002 and July 2004, 3274 uncircumcised males, aged [18 ] 18 to 24, were recruited, randomized into two groups and followed-up. Recruitment was conducted independently of HIV and HSV-2 status. Male circumcision was offered to the intervention group immediately after randomization and to control group participants after the end of the follow-up period. During each follow-up visits at 3 (M3), 12 (M12) and 21 (M21) months, circumcision status was ascertained by a nurse by genital examination and a blood sample was obtained. In addition, information about sexual behavior was collected, including number of sexual partners as a function of time and history of condom use with each sexual partner.
The dataset used in this study included 590 additional 21-month follow-up visits (20.0 of the total number of 21-month visits) which % were not included when the analysis of the effect of male circumcision on HIV was published because corresponding biological data were not available at that time.
Laboratory methods
Plasma specimens were extracted from each blood sample immediately after collection, frozen at 20 C and kept frozen until −°p rocessing. They were tested using an HSV type 2 specific IgG assay to detect HSV-2 antibodies with an index cutoff value of 1.1 (Kalon HSV-2 gG2 assay; Kalon Biologicals Ltd., Aldershot, UK), according to the manufacturer s recommendations.
'
Data analysis
HIV status, treated as censored data with time being continuous, was established at each follow-up visit for periods of non-uniform duration. These data were modeled using a piecewise exponential proportional hazards model in which the baseline hazard was considered constant between consecutive follow-up visits. This theoretical model was established to take into account the precise duration between each visit as well as the time-dependent covariates. It was implemented by running a Poisson log-linear model on a dataset with each line corresponding to one of three periods of follow-up: from randomization (M1) to M3, from M3 to M12 and from M12 to M21. During these periods participants remained HIV negative or became HIV positive . HIV incidence rates (IRs) and incidence rate ratios [22 -24 ] (IRRs) were thus estimated for the intervention and control groups (intention-to-treat analysis, ITT) and for circumcised and uncircumcised men (as-treated analysis, AT). The participants sociodemographic factors were age, religion, ethnic group and alcohol consumption. The reported sexual behavior ' covariates were, for each period of follow-up, sexual risk behavior (defined as having at least one sexual contact unprotected by a condom), having a spousal partner and number of non-spousal sexual partners.
To assess the relative importance of HSV-2 seropositivity on HIV incidence among young men, the proportion of HIV incident cases attributable to HSV-2 seropositivity was computed using the formula given by Bruzzi and colleagues . 95 confidence intervals (95 [25 ] % % CI) were obtained by bootstrapping.
The effect of HSV-2 status on the protective effect of male circumcision on HIV acquisition by men was assessed by testing the corresponding interaction term.
The piecewise exponential proportional hazards model was repeated to identify the risk factors of HSV-2 incidence.
In order to account for 1) the median time to seroconversion (window period) estimated at 120 days for the assay used and 2) the [26 ] healing period following male circumcision, the effect of male circumcision on HSV-2 was analyzed for the period M12 M21. This
period included all those tested for HSV-2 at least 240 days after male circumcision. The other factors were studied for the period M1-
M12.
Furthermore, since HIV infection is reduced by male circumcision and associated with HSV-2 infection , , the [18 -20 ] [27 28 ] analyses of the association between HSV-2 and male circumcision were repeated excluding those who HIV seroconvert during follow-up in order to determine whether the effect of male circumcision on HSV-2 was affected by HIV acquisition during follow-up.
Lastly, the association between HSV-2 incidence and health-seeking behavior, defined as at least one visit to a clinic for a genital problem during the 12-month period prior to a visit to the centre, was studied separately, univariately and multivariately, using male circumcision status and the cofactors listed above.
The confidence intervals of the percentages were calculated using Bayesian estimation . Statistical analyses were performed using [29 ] the statistical package SPSS for Windows version 8 (SPSS, Chicago, Illinois, United States) and R (version 2.6.2) for analysis .
[30 ]
Complementary epidemiological data
To estimate HSV-2 prevalence by age and gender among the population of Orange Farm we used the data from a representative sample of 436 men and 476 women aged 15 to 49 from the community. These data were collected during a cross-sectional survey conducted in 2002 . Blood samples were tested for HSV-2 serostatus using the same HSV-2 assay as the one used in the present study.
[31 ]
For men and women, HSV-2 prevalences were 31.7 95 CI, 27. 
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Population characteristics
Among the 3274 participants enrolled in the trial, 5.9 were HSV-2 positive and 4.4 were HIV positive. 2974 participants were 
HIV incidence and HIV incidence rate ratio
73 new HIV infections were diagnosed during follow-up. indicates the effect of HSV-2 status during follow-up on HIV Table 1 incidence: HIV incidence rate ratio was significantly higher among participants who were HSV-2 positive at recruitment and among participants who became HSV-2 positive during follow-up than among participants who stayed HSV-2 negative during follow-up. The HIV incidence rate ratio was about twice as high among those who became HSV-2 positive than among those who were HSV-2 positive at baseline, with a borderline level of significance, IRR, 2.2 95 CI, 0.95 5.1 ; P .067 and aIRR, 2.1 95 CI: 0.87 5.1 ; P .098. 
Population attributable fraction
among participants who got infected with HSV-2 during follow-up. 4 9 Among 
HIV positive.
presents the number of HSV-2 infections observed during follow-up and the univariate effect of male circumcision on HSV-2 Table 2 incidence as a function of the randomization group and circumcision status. There was a borderline protective effect in the ITT analysis and the effect became stronger and significant in the AT analysis. When both analyses were repeated for the follow-up period M1 M21, presents the ITT and AT multivariate analyses of HSV-2 incidence. In both instances, the value of the protective effect of male Table 3 circumcision and its level of statistical significance were close to the corresponding univariate values ( ). HSV-2 incidence was Table 2 significantly associated with older age, sexual risk behavior and HIV status at enrollment.
illustrates the strong association of HIV Table 4 status on HSV-2 acquisition during follow-up. that the observed effect of male circumcision on HSV-2 acquisition cannot be due to the effect of male circumcision on HIV acquisition.
Attendance at a health clinic for a health problem related to the genitals
The percentage of participants who attended a clinic for a health problem related to the genitals in the past 12 months was 10. (IRR, 4.55 95 CI, 2.94 7.02 ; P < .001) and the multivariate analysis (aIRR, 3.31 95 CI, 2.12 5.18 ; P < .001).
[
Discussion
The primary aim of this study was to assess the role of HSV-2 status on HIV acquisition by men, using data collected during a male circumcision trial conducted in Orange Farm (South Africa).
We found a strong association between the incidences of these two viruses. Such association may be due to the fact that the viruses are both sexually transmitted and must share risk factors. It may also be due to the fact that one virus increases the risk of transmission of the other , . [2 11 -14 ] This study was conducted in an area with high HIV and HSV-2 prevalences among adults , . As shown by the data of a [32 33 ] cross-sectional survey, the relatively low HSV-2 prevalence among our sample is likely due to the fact that participants were young men.
The population fraction of HIV incidence among young men due to HSV-2 in this study was around a quarter, value close to the lower bound of the estimates, ranging from 25 to 48 , obtained by modeling studies , . These results suggest an overall substantial . This can be explained by the fact that acyclovir does not [36 ] cure HSV-2 infection.
Our results also suggested with a borderline significance level that HIV incidence may be twice as high among those who became HSV-2 positive than among those who were HSV-2 positive at baseline. These results concur with those from a study, conducted among commercial sex workers in South Africa , which suggested that recent HSV-2 seroconversion appeared more important than established [9 ] HSV-2 infection for the acquisition of HIV. Finally, we found that the protective effect of male circumcision on HIV acquisition was not altered by HSV-2 status or HSV-2 acquisition.
In terms of risk factor for HSV-2, our findings indicated that participants who were HIV positive at enrollment were more likely to acquire HSV-2. There was an independent and protective effect of male circumcision on HSV-2 acquisition by young males, which was significant only in the AT analysis. This effect was diluted and the statistical significance was lower in the ITT analysis, which can be attributed to the cross-over of 8.2 of participants in this study . In the ITT analysis, the size of the protective effect of male
circumcision on HSV-2 acquisition observed in this study was consistent with the results of a meta-analysis of observational studies which showed a relative risk of 0.88 95 CI, 0.77 1.01 , and the preliminary results from the Rakai male circumcision trial . However
the AT analysis suggested a strong protective effect of MC against HSV-2 acquisition.
There are some limitations to this study: First, the window period of HSV-2 testing may impact the prevalence and incidence of HSV-2. Secondly, the crossover of participants was 8.2 and may explain the discrepancy between results from the ITT and AT analyses.
% Thirdly, the sample included young men among whom HIV and HSV-2 prevalence is relatively low compared to the general population, so our findings may not be generalized. Finally, the participants were taking part in a randomized controlled trial, so there may have been a selection bias.
This study provides additional evidence supporting the promotion of male circumcision in Africa: male circumcision has the potential to reduce the female-to-male transmission of HSV-2 and thus the spread of HSV-2, in addition to being a method proven to reduce the female-to-male transmission of HIV. The protective effect of male circumcision on HSV-2 is another argument in favor of rolling-out male circumcision in African countries were most males are uncircumcised . [38 ] Because of the complex interplay between HSV-2, HIV and male circumcision, further studies, in particular modeling studies, are needed to better understand their interactions; not only in the short term, as studied by randomized controlled trials, but also in the long term. Such studies should provide a comprehensive investigation of the epidemiological and geographical distribution of HIV and HSV-2 in Africa, taking male circumcision prevalence into account. Part of the effect of male circumcision on HIV may be attributed to its effects on HSV-2, such as the reduction of genital herpetic lesions which are associated with HSV-2 infection and may facilitate HIV transmission. However, this study contends that this effect is limited at population level. 4 Defined as having at least one sexual contact not protected by condom. 5 At some time in the past 3-month period before M3, and in the past 9-month period before M12 and M21. 6 In the past 3-month period before M3, and in the past 9-month period before M12 and M21. 
